Veracyte | VCYT - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Agenus USD 33.74M 468K 2026-03
Agilent USD 1.04B 52M 2026-06
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 75.25M 1.52M 2026-06
Bruker USD 416M 36.2M 2026-06
Heron Therapeutics USD 29.47M 3.17M 2025-12
Illumina USD 770M 49M 2026-06
Intrexon USD -297K 167K 2024-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Laboratory Of America USD 1.11B 98.2M 2026-06
Ligand Pharmaceuticals USD 100.41M 51.96M 2026-06
Myriad Genetics USD 146.8M 3M 2025-12
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Siemens EUR 7.68B 51M 2026-03
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veracyte USD 108.55M 7.39M 2026-06
Waters USD 490M 52M 2026-06